Low calorie sweeteners and gut microbiota: Why is there a debate?

A presentation by Prof Ian Rowland at the ISA Conference 2018
The human colonic microbiota is a large and complex microbial community. Over 1000 bacterial species have been identified with about 160 being found in the gut of any individual. The size and diversity of the microbiota is reflected in extensive metabolic activities.

Observational studies comparing the faecal microbiotas of healthy subjects with those of patients, strongly suggest an association of gut microbiota composition and the aetiology and/or development of a range of gastrointestinal diseases and also a link with obesity and diabetes. However, the precise organisms involved are difficult to identify. The interactions of low/no calorie sweeteners (LCNS) and gut microbiota has been the subject of numerous studies in laboratory animals and human subjects. LNCS are a structurally diverse group of compounds that have very different metabolic fates following consumption. Most (e.g. acesulfame K, saccharin, and sucralose) are not metabolized by gut bacteria. Stevia is a notable exception as its glycosidic forms are hydrolysed by the microbiota, releasing steviol, which is then absorbed intact without further bacterial metabolism.

LNCS are consumed at such low levels that they are unlikely to have a direct, clinically meaningful impact on the gut microbiota. Nevertheless, a few studies on saccharin have shown effects on microbiota composition or metabolism, although only at very high doses above normal human consumption. Studies with other LCNS show either no, or inconsistent, effects on the microbiota, probably as a consequence of design issues and lack of adequate controls. Overall, the evidence indicates that LCNS have minimal impact on gut microbiota.

Webinar SAN-ISA: «Salud, sabor dulce y placer – es factible?»

Highlights from the ISA Conference 2018

Sweet taste, appetite and obesity: Is there a link?